GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Price, Quote, News and Overview
NYSE:GRDN - New York Stock Exchange, Inc. - US40145W1018 - Common Stock - Currency: USD
GRDN Quote, Performance and Key Statistics
GUARDIAN PHRMCY SERVICES-A
NYSE:GRDN (1/24/2025, 8:04:01 PM)
After market: 21.58 0 (0%)21.58
+0.49 (+2.32%)
The current stock price of GRDN is 21.58 USD. In the past month the price decreased by -8.75%.
GRDN Latest News, Press Releases and Analysis
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
GRDN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC | 4.35 | 10.25B | ||
| YI | 111 INC | N/A | 452.31M | ||
| CJJD | CHINA JO-JO DRUGSTORES HOLDI | N/A | 11.70M | ||
| MGRX | MANGOCEUTICALS INC | N/A | 9.21M |
Related stock screener links
About GRDN
Company Profile
Guardian Pharmacy Services Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Atlanta, Georgia. The company went IPO on 2024-09-26. Guardian Pharmacy Services, Inc. is a United States-based pharmacy services company. The firm provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimen. Through its locally based pharmacies, the Company utilizes a technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its services include GuardianShield, provider services, and others. Its Guardian Compass platform offers insights to enhance efficiencies for its pharmacies, including real-time operational dashboards and metrics. The company serves assisted living and memory care, hospice care and others.
Company Info
GUARDIAN PHRMCY SERVICES-A
300 Galleria Parkway SE, Suite 800
Atlanta GEORGIA US
Employees: 3200
Company Website: https://guardianpharmacy.com/
Phone: 14048100089
GRDN FAQ
What is the stock price of GRDN?
The current stock price of GRDN is 21.58 USD.
What is the symbol for GUARDIAN PHRMCY SERVICES-A stock?
The exchange symbol of GUARDIAN PHRMCY SERVICES-A is GRDN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is GRDN stock listed?
GRDN stock is listed on the New York Stock Exchange, Inc. exchange.
Is GRDN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GRDN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GRDN.
Does GRDN stock pay dividends?
GRDN does not pay a dividend.
What is the Price/Earnings (PE) ratio of GRDN?
GRDN does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.62).
What is the Short Interest ratio of GRDN stock?
The outstanding short interest for GRDN is 9.51% of its float.
GRDN Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to GRDN.
GRDN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GRDN. GRDN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
GRDN Financial Highlights
Over the last trailing twelve months GRDN reported a non-GAAP Earnings per Share(EPS) of -1.62. The EPS decreased by -33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -28.18% | ||
| ROE | -76.89% | ||
| Debt/Equity | 0.3 |
GRDN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to GRDN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -424.79% and a revenue growth 18.05% for GRDN